Vimarsana
Biggest News Aggregation in the World

Rev Genet News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rev Genet. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rev Genet Today - Breaking & Trending Today

Postdoctoral Fellowships in Cancer Biology, CRISPR, and Epigenetics job with The University of Texas MD Anderson Cancer Center - Vimarsana News

Postdoctoral Fellowships in Cancer Biology, CRISPR, and Epigenetics job with The University of Texas MD Anderson Cancer Center

Postdoctoral Fellowships in Cancer Biology, CRISPR, and Epigenetics job in Houston, Texas (US) with The University of Texas MD Anderson Cancer Center. Apply Today.

Source: nature.com
Perfused Organ Models An Alternative To Animal Testing - Vimarsana News

Perfused Organ Models An Alternative To Animal Testing

Animal testing has been a long-standing practice in biomedical research, providing valuable insights into disease mechanisms, drug efficacy, and...

Machine learning-based marker for coronary artery disease: derivation and validation in two longitudinal cohorts - Vimarsana News

Machine learning-based marker for coronary artery disease: derivation and validation in two longitudinal cohorts

Electronic health record-based machine learning was used to generate an in-silico marker for coronary artery disease that can non-invasively quantify atherosclerosis and risk of death on a continuous spectrum, and identify underdiagnosed individuals.

A Multiphoton Microscope Enables Portable 3D Biological Imaging | Features | Sep/Oct 2022 - Vimarsana News

A Multiphoton Microscope Enables Portable 3D Biological Imaging | Features | Sep/Oct 2022

For decades, optical microscopy has provided the mechanism with which to image cells and tissue for the purposes of cancer research, digital pathology

Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) toAdvance Clinical Research of Infectious Diseases - Vimarsana News

Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) toAdvance Clinical Research of Infectious Diseases

Waters Corporation (NYSE:WAT) today introduced a new RUO LC-MS test method to advance critical infectious disease research. Waters™ SARS-CoV-2 LC-MS Kit (RUO) uses an orthogonal analytical method that directly detects and quantifies SARS-CoV-2 Nucleocapsid (NCAP) peptides that initial studies have shown to yield highly accurate, quantitative results.